4//SEC Filing
MORE ROBERT J 4
Accession 0001628280-23-034785
CIK 0001706431other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 2:15 PM ET
Size
7.4 KB
Accession
0001628280-23-034785
Insider Transaction Report
Form 4
MORE ROBERT J
Director
Transactions
- Other
Common Stock
2023-10-19+6,405→ 495,890 total(indirect: See footnote) - Other
Common Stock
2023-10-19−6,405→ 38,683 total
Footnotes (3)
- [F1]Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred for no consideration to APNG 1 in connection with the vesting of an RSU award. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG 1. As such, the Reporting Person may be deemed to beneficially own the shares held by APNG 1. However, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.
- [F2]Shares transferred for no consideration to APNG 1 upon vesting of an RSU award held by the Reporting Person for the benefit of APNG 1.
- [F3]The shares are held by APNG 1. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG I. The Reporting Person may be deemed to beneficially own the shares held by APNG 1, and disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001207792
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 2:15 PM ET
- Size
- 7.4 KB